Announcement on the Resale of "13 Spike 02" Corporate Bonds
Release time:
2020-08-05
股票代码:600668 股票简称:尖峰集团 公告编号:临2017-027
债券简称:13尖峰01 债券代码:122227
债券简称:13尖峰02 债券代码:122344
浙江尖峰集团股份有限公司
关于“13尖峰02”公司债券回售的公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
重要提示:
● 回售代码:100934
● 回售简称:尖峰回售
● 回售价格:100元/张。
● 回售申报期:2017年10月13日至2017年10月19日。
● 回售款到账日:2017年11月20日
● 债券利率是否调整:不调整
特别提示:
1、根据《浙江尖峰集团股份有限公司公开发行公司债券(第二期)募集说明书》,发行人有权决定是否在本期债券存续期的第3年末上调本期债券后2年的票面利率。本期债券在存续期前3年票面利率为5.09%,在本期债券的第3年末,公司选择不调整本期债券票面利率,即本期债券后2年票面利率为5.09%并保持不变。
2、根据《浙江尖峰集团股份有限公司公开发行公司债券(第二期)募集说明书》设定的回售选择权,发行人发出关于是否上调本期债券票面利率及上调幅度的公告后,投资者有权选择将持有的本期债券全部或部分按面值回售给发行人,或选择继续持有本期债券。
3、 “13尖峰02”债券持有人,可按照本公告规定,在回售申报期对其所持有的全部或部分“13尖峰02”债券进行回售申报登记。本次回售申报期内不进行申报的,视为放弃回售选择权,继续持有本期债券并接受上述关于维持“13尖峰02”票面利率的决定。
4、“13尖峰02”债券持有人的回售申报一经确认后不能撤销,相应的债券将冻结交易,直至本次回售实施完毕后相应债券被注销。
5、本次回售等同于“13尖峰02”债券持有人于本期债券第3个计息年度付息日,以100元/张的价格卖出“13尖峰02”债券,请“13尖峰02”债券持有人慎重判断本次回售的风险。
6、本公告仅对“13尖峰02”债券持有人申报回售的有关事宜作简要说明,不构成对申报回售的建议,“13尖峰02”债券持有人欲了解本期债券回售的详细信息,请通过上海证券交易所网站(http://www.sse.com.cn)查阅相关文件。
7、本次回售资金发放日指公司向本次有效申报回售的“13尖峰02”债券持有人支付本金及当期利息之日,即2017年11月20日。
为保证发行人上调票面利率选择权和投资者回售选择权有关工作的顺利进行,现将有关事宜公告如下:
一、释义
|
发行人、公司、尖峰集团 |
指 |
浙江尖峰集团股份有限公司 |
|
13尖峰02、本期债券 |
指 |
浙江尖峰集团股份有限公司2013年公司债券(第二期) |
|
公司债券 |
指 |
公司依照法定程序发行、约定在一定期限还本付息的有价证券 |
|
本次回售 |
指 |
“13尖峰02”债券持有人可选择将其持有的全部或部分“13尖峰02”公司债券在本期债券第3个计息年付息日按面值回售给本公司 |
|
本次回售申报期 |
指 |
“13尖峰02”持有人可以申报本次回售的期间,即2017年10月13日至2017年10月19日 |
|
付息日 |
指 |
“13尖峰02”公司债券的利息每年支付一次,为债券存续期每年的11月20日(遇法定节假日或休息日,顺延至其后的第1个工作日;每次付息款项不另计利息) |
|
回售资金发放日 |
指 |
本公司向本次有效申报回售的“13尖峰02”持有人支付本金及当期利息之日,即“13尖峰02”债券存续期间第3个付息日,即2017年11月20日 |
|
上交所 |
指 |
上海证券交易所 |
|
登记机构 |
指 |
中国证券登记结算有限责任公司上海分公司 |
|
元 |
指 |
人民币元 |
二、本期债券基本情况
1、债券名称:浙江尖峰集团股份有限公司2013年公司债券(第二期)。
2、债券简称及代码:13尖峰02、122344
3、发行人:浙江尖峰集团股份有限公司
4、发行规模:人民币3亿元。
5、债券期限:本期债券的期限为5年(附第3年末发行人上调票面利率选择权和投资者回售选择权)。
6、债券利率或其确定方式:本期债券票面利率在债券存续期的前3年固定不变。如发行人行使上调票面利率选择权,未被回售部分债券存续期限后2年票面年利率为债券存续期限前3年票面年利率加上调基点,在债券存续期限后2年固定不变。如发行人未行使上调票面利率选择权,则未被回售部分债券在存续期限后2年票面利率仍维持原有票面利率不变。本期公司债券票面利率由发行人和保荐人(主承销商)通过市场询价协商确定。
7、发行人上调票面利率选择权:发行人有权决定是否在本期债券存续期的第3年末上调本期债券后2年的票面利率。发行人将于本期债券第3个计息年度付息日前的第30个交易日,在中国证监会指定的上市公司信息披露媒体上发布关于是否上调本期债券票面利率以及上调幅度的公告。若发行人未行使利率上调选择权,则本期公司债券后续期限票面利率仍维持原有票面利率不变。
8、投资者回售选择权:发行人发出关于是否上调本期债券票面利率及上调幅度的公告后,投资者有权选择将持有的本期债券全部或部分按面值回售给发行人。若投资者行使回售选择权,本期债券第3个计息年度付息日即为回售支付日,发行人将按照交易所和债券登记机构相关业务规则完成回售支付工作。
9、回售申报:自发行人发出关于是否上调本期债券票面利率及上调幅度的公告日起5个交易日内,债券持有人可通过指定方式进行回售申报。债券持有人的回售申报经确认后不能撤销,相应的公司债券份额将被冻结交易;回售申报期不进行申报的,则视为放弃回售选择权,继续持有本期债券并接受发行人关于是否上调本期债券票面利率及上调幅度的决定。
10、债券形式:实名制记账式公司债券。投资者认购的本期债券在债券登记机构开立的托管账户托管记载。本期债券发行结束后,债券持有人可按照有关主管机构的规定进行债券的转让、质押等操作。
11、还本付息方式:采用单利按年计息,不计复利。每年付息一次,到期一次还本,最后一期利息随本金的兑付一起支付。若债券持有人在第3年末行使回售选择权,回售部分债券的票面面值加第3年的利息在投资者回售支付日一起支付。
12、上市时间和地点:本期债券于2014年12月11日在上海证券交易所上市交易。
三、本期债券回售实施办法
1、回售代码:100934 回售简称:尖峰回售
2、回售申报期:2017年10月13日至2017年10月19日。
3、回售价格:人民币100元/张(不含利息)。以1,000元为一个回售单位,回售金额必须是1,000元的整数倍且不少于1,000元。
4、回售申报办法:投资者可选择将持有的债券全部或部分回售给发行人,在回售申报期内通过上海证券交易所交易系统进行回售申报,当日可以撤单,每日收市后回售申报一经确认,不能撤销。如果当日未能申报成功,或有未进行回售申报的债券余额,可于次日继续进行回售申报(限申报申报期内)。
5、选择回售的投资者须于回售申报期内进行登记,逾期未办理回售申报手续即视为投资者放弃回售,同意继续持有本期债券。
6、回售部分债券兑付日:2017年11月20日。发行人委托中国证券登记结算有限责任公司上海分公司为申报回售的债券持有人办理兑付。
7、风险提示:投资者选择回售等同于投资者以100元/张(不含利息)的价格卖出“13尖峰02”,投资者参与回售可能会带来损失,请“13尖峰02”债券持有人慎重判断本次回售的风险。
四、回售部分债券付款情况
1、回售资金到帐日:2017年11月20日。
2、回售部分债券享有2016年11月20日至2017年11月19日期间利息,票面年利率为5.09%。每手债券(面值人民币1,000元)派发利息为人民币50.90元(含税),扣税后个人投资者、证券投资基金债券持有人取得的实际每手债券派发利息为40.72元;扣税后非居民企业(包含QFII、RQFII)取得的实际每手债券派发利息为45.81元。
3、付款方式:发行人将依照中国证券登记结算有限责任公司上海分公司的登记结果对本期债券回售部分支付本金及利息,该回售资金通过中国证券登记结算有限责任公司上海分公司清算系统进入投资者开户的证券公司的登记公司备付金账户中,再由该证券公司在回售资金到帐日划付至投资者在该证券公司的资金账户中。
五、回售申报期间的交易
本期债券在回售申报期内将继续交易。回售部分债券在回售申报截止日收市后将被冻结。
六、回售价格
根据《浙江尖峰集团股份有限公司公开发行公司债券(第二期)募集说明书》的有关约定,回售价格为债券面值(100元/张)。
七、回售申报期
2017年10月13日至2017年10月19日
八、回售申报程序
1、申报回售的“13尖峰02”债券持有人应在2017年10月13日至2017年10月19日正常交易时间(9:30-11:30,13:00-15:00),通过上交所交易系统进行回售申报,申报代码为100934,申报方向为卖出,回售申报一经确认后不能撤销,相应的债券将被冻结交易,直至本次回售实施完毕后相应债券被注销。在回售资金发放日之前,如发生司法冻结或扣划等情形,债券持有人的该笔回售申报业务失效。
2、“13尖峰02”债券持有人可对其持有的全部或部分有权回售的债券申报回售。“13尖峰02”债券持有人在本次回售申报日不进行申报的,视为对回售选择权的无条件放弃。
3、对“13尖峰02”债券持有人的有效回售申报,公司将在本年度付息日(2017年11月20日)委托登记机构通过其资金清算系统进行清算交割。
九、回售实施时间安排
|
时间 |
工作内容 |
|
2017年10月9日 |
发布本次回售公告 |
|
2017年10月9日 |
发布是否调整票面利率的公告 |
|
2017年10月10日 |
发布本次回售的第一次提示性公告 |
|
2017年10月11日 |
发布本次回售的第二次提示性公告 |
|
2017年10月12日 |
发布本次回售的第三次提示性公告 |
|
2017年10月13日至2017年10月19日 |
本次回售申报期 |
|
2017年10月24日 |
发布本次回售申报情况的公告 |
|
2017年11月20日 |
发布关于回售实施结果的公告 |
|
2017年11月20日 |
回售资金到账日 |
十、风险提示及相关处理
1、本次回售等同于“13尖峰02”持有人于债券存续期间第3个计息年度付息日(2017年11月20日),以100元/张的价格(净价)卖出“13尖峰02”债券。请“13尖峰02”持有人对是否行使回售选择权进行慎重判断并作出独立决策,本公告不构成对本期债券持有人是否行使回售选择权的建议。
2、上交所对公司债券实行“净价交易,全价结算”,即“13尖峰02”按净价进行申报和成交,以成交价格和应计利息额之和作为结算价格。
十一、关于本次回售所付利息缴纳所得税的说明
(一)关于向个人投资者征收企业债券利息所得税的说明
根据《中华人民共和国个人所得税法》以及其他相关税收法规和文件的规定,本期债券个人投资者应缴纳公司债券个人利息收入所得税。本期债券利息个人所得税将由各兑付机构负责代扣代缴,并直接向各兑付机构所在地的税务部门缴付。本期债券的个人利息所得税征缴说明如下:
1、纳税人:本期债券的个人投资者;
2、征税对象:本期债券的利息所得;
3、征税税率:按利息额的20%征收;
4、征税环节:个人投资者在兑付机构领取利息时由兑付机构一次性扣除;
5、代扣代缴义务人:负责本期债券付息工作的各兑付机构。
6、本期债券利息税的征管部门:各兑付机构所在地的税务部门。
(二)关于向非居民企业征收企业债券利息所得税的说明
对于持有“13尖峰02”的合格境外机构投资者等非居民企业(其含义同《中华人民共和国企业所得税法》),根据2008年1月1日起施行的《中华人民共和国企业所得税法》及其实施条例、2009年1月1日起施行的《非居民企业所得税源泉扣缴管理暂行办法》(国税发[2009]3号)以及2009年1月23日发布的《关于中国居民企业向QFII支付股息、红利、利息代扣代缴企业所得税有关问题的通知》(国税函[2009]47号)等规定,非居民企业取得的发行人本期债券利息应当缴纳10%的企业所得税,中国证券登记结算有限责任公司上海分公司将按10%的税率代扣相关非居民企业上述企业所得税,在向非居民企业派发债券税后利息,将税款返还债券发行人,然后由债券发行人向当地税务部门缴纳。
十二、本期债券回售的相关机构
1、发行人:浙江尖峰集团股份有限公司
住所:浙江省金华市婺江东路88号
法定代表人:蒋晓萌
联系人:朱坚卫、周恒斌
联系电话:0579-82320582、82324699
传真:0579-82320582、82324699
2、主承销商:浙商证券股份有限公司
法定代表人:吴承根
住所:浙江省杭州市江干区五星路201号
联系人:华佳、马岩笑
联系电话:0571-87902082、87903124
传真:0571-87903239
3、托管人:中国证券登记结算有限责任公司上海分公司
地址:上海市陆家嘴东路166 号中国保险大厦3层
联系人:徐瑛
电话:021-68870114
传真:021-68875802
邮政编码:200120
特此公告。
浙江尖峰集团股份有限公司
董事会
2017年10月9日
More information
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-30
Peak Pharmaceutical Becomes National Intellectual Property Demonstration Enterprise
Just one year after it was identified as a national intellectual property advantage enterprise in 2016, "Zhejiang Jianfeng Pharmaceutical Co., Ltd." appeared in the list of national intellectual property demonstration enterprises in 2017 recently announced by the State Intellectual Property Office. As a result, Jianfeng Pharmaceutical has become the first and only national intellectual property demonstration enterprise in Jinhua City. On December 12, the State Intellectual Property Office issued a notice to announce the list of national intellectual property demonstration enterprises and advantageous enterprises in 2017. After the enterprise declaration, the recommendation of the provincial and municipal bureaus, the review of the national bureau, and the public announcement, 182 national intellectual property demonstration enterprises and 816 national intellectual property advantage enterprises have been identified. Including Jianfeng Pharmaceutical, Zhejiang Province has been identified as only 15 national intellectual property demonstration enterprises. With the continuous development of enterprises in recent years, Jianfeng Pharmaceutical has set up a special working organization to cultivate and improve the intellectual property ability from the aspects of strategic management, creation, operation and protection of intellectual property rights. It has successively compiled and implemented 27 procedural documents and 36 forms such as "Intellectual Property Management Manual", "Intellectual Property Reward and Punishment System" and "Trade Secret Management System, and timely according to the policy, the current situation of the enterprise to revise, in order to ensure the compliance and effectiveness of the operation of the system. In 2012 and 2013, Jianfeng Pharmaceutical was successively rated as a patent demonstration enterprise in Jinhua City and Zhejiang Province; in 2013, it won the third prize of Jinhua Patent Implementation Award; in 2016, it passed the certification of intellectual property management system and was identified as a national intellectual property advantage enterprise. Currently, Peak Pharmaceuticals has
2020
07-31
Jianfeng Pharmaceutical Approved to Set up Provincial Research Institute
A few days ago, the relevant departments of Zhejiang Province approved the establishment of the provincial research institute of the peak pharmaceutical company. This is another honor won by Jianfeng Pharmaceutical in the field of independent research and development and scientific and technological innovation after the national postdoctoral research workstation and Zhejiang academician expert workstation. The provincial enterprise research institute is a high-level R & D institution led by the Provincial Department of Science and Technology, jointly recognized by the Provincial Economic and Information Commission and the Provincial Development and Reform Commission. As an important part of the national technological innovation system, the Enterprise Research Institute is the core force of the innovation-driven development of Jianfeng Pharmaceutical, which reflects the ability of Jianfeng Pharmaceutical to set up higher-level and higher-level R & D institutions on its own. the ability to gather and integrate innovation elements, organize scientific and technological innovation, support the sustainable development of enterprises, and lead the technological progress of the industry. As a pharmaceutical enterprise, scientific and technological innovation is the eternal theme of enterprise development, and talent is the key to scientific and technological innovation. Over the years, Jianfeng Pharmaceutical has not only focused on cultivating its own scientific research talents, but also established close cooperative relations with well-known universities and scientific research institutions such as China Pharmaceutical University, Shenyang Pharmaceutical University, Sichuan Antibiotic Industry Research Institute, and also focused on introducing top think tanks. In 2011, Professor Liu Jiajian and his team from Sichuan Institute of Antibiotic Industry were introduced, focusing on the technical research of key intermediates of methoxy cephalosporin. In 2013, Professor Shan Weiguang and his scientific research team from Zhejiang University of Technology were introduced to carry out research on preparation technology. In 2015, Professor Wang Guangji, academician of the Chinese Academy of Engineering, was hired as the chief scientist to organize the research on the anti-drug resistance mechanism of national class I new drugs by intracellular pharmacokinetics. In 2017 with Shanghai antibody
2020
07-31
On November 16, the company held the first extraordinary general meeting of shareholders in 2017, which deliberated and passed the proposal on the expiration of the term of the board of directors and the proposal on the expiration of the term of the board of supervisors, and elected a new board of directors and the board of supervisors. The meeting used a combination of on-site registered voting and online voting to vote on director candidates one by one, and elected Jiang Xiaomeng, Du Zihong, Yu Jianhong, Huang Sujian, Liu Bo, Zhang Guoping, Huang Conyun, Sun Hongbin, and Shi Ximin as the company's tenth board of directors. Directors, of which Huang Conyun, Sun Hongbin, and Shi Ximin are independent directors. The meeting used a combination of on-site registered voting and online voting to vote on supervisor candidates one by one, and elected Chen Tianci, Lu Ruimei, and Shi Fu as supervisors of the company's ninth board of supervisors. Prior to this, the company's trade union held an enlarged meeting of the trade union committee to elect Qin Xuping and Jin Huazhong as employee representative supervisors of the ninth board of supervisors. On the same day, the company's tenth board of directors held its first meeting and elected Jiang Xiaomeng as the chairman of the tenth board of directors. Jiang Xiaomeng, Du Zihong, Huang Sujian, Sun Hongbin and Shi Ximin were elected as members of the Strategy Committee of the 10th Board of Directors, and Jiang Xiaomeng was the chairman of the Strategy Committee. Shi Ximin, Huang Conyun and Jiang Xiaomeng were elected as members of the audit committee of the 10th board of directors, and Shi Ximin was the chairman. Sun Hongbin, Huang Conyun and Jiang Xiaomeng were elected as members of the nomination committee of the 10th board of directors, and Sun Hongbin was the chairman. Huang Cong Yun, Shi Ximin and Du Zihong were elected as members of the remuneration and assessment committee of the 10th board of directors, and Huang Cong Yun was the chairman. The board of directors appointed Yu Jianhong as the general manager of the company and appointed Huang Jinlong.
2020
07-31
Peak natural products pollution control results by the industry attention
As a leader in China's plant extracts industry, Tianjin Jianfeng Natural Products Company has achieved fruitful results in technological innovation. On October 26 and 27, at the 2017 Forum on improving the international competitiveness of China's plant extract industry held in Handan City, Hebei Province, Liu Dan, general manager of the company, delivered a speech entitled "prevention and control of water pollution in the field of plant extraction", introducing the successful experience of sewage treatment in the past five years, which was widely concerned by the participants. In recent years, environmental protection and ecology have become hot words for the development of enterprises and society. Due to the particularity of the plant extraction industry, pollution control in this industry has different characteristics and requirements from ordinary production enterprises. For example, sewage presents higher chroma, extremely low PH value, more suspended solids, high salinity, high concentration of COD, and different sewage water quality of different products. As the earliest enterprise producing opc grape seed extract in China, Natural Products Company has always attached great importance to the pollution control of plant extraction. For example, in the sewage treatment upgrading project implemented in 2016, ozone oxidation and biochemical methods were adopted to remove the remaining organic pollutants, increasing the sewage treatment capacity from 200 cubic meters per day to 500 cubic meters. The latest anaerobic sewage treatment technology is adopted, the COD emission value of the outlet is reduced to 60 mg per liter, which is far lower than the national first-class emission standard of 100 mg per liter. The new system adopts advanced oxidation reaction tower, ozonation method, field energy reactor and sludge adsorption reflux technology, which can quickly and efficiently treat organic pollutants with strong chemical stability without adding any chemicals.
2020
07-31